Data Management STREAM
-
Importance And Requirements Of Study Results Posting
1/15/2020
In addition to laws requiring disclosure of clinical trial results, the public also demands this information. TrialScope Chief Strategy Officer Thomas Wicks explains why sponsors should share study results.
-
The Importance Of Reliable Data To Clinical Trial Activation
5/8/2025
Find an easier way to identify and enroll eligible patients for your clinical trials with quality data and site selection.
-
Sitetrove: Industry-Leading Global Investigator And Site Intelligence
1/20/2022
With over 500,000 investigators and more than 180,000 clinical trial sites spanning 185 countries, Sitetrove provides the data vital to accurately assessing target locations, identifying qualified investigators, and prioritizing candidates for clinical trial success.
-
The Impact Of AI On Mobile Visits
9/5/2024
Experts discuss the FDA's new AI guidance, global harmonization, and the ethical implications of AI in clinical trials. Discover the challenges and opportunities ahead.
-
Navigating Trials With Confidence: Building A Robust External Control Arm
12/21/2023
Explore methods to build scientifically rigorous comparator groups to allow more patients access to life-saving treatments, accelerate trial timelines, and maximize resources.
-
Some Top Concerns When Implementing AI In Clinical Trials
1/27/2025
Everything from fear of loss of personal privacy to risk bias can be a concern when implementing AI in clinical trials.
-
Medidata Clinical Data Management
4/24/2024
By automating complex tasks, Medidata Rave simplifies clinical data management and capture. This leads to cleaner, more reliable data, allowing for quicker analysis and results.
-
Qdata From Verana Health For HEOR And Medical Affairs
5/8/2025
Obtain real-world data on patient demographics, treatment patterns, and outcomes to help inform your future business decisions.
-
How Data Impacts GBM/RGB Clinical Trials?
8/25/2022
In this video, Elizabeth Lamont, Senior Medical Director for Medidata AI, describes how an external control arm can be used in rGBM/GBM and the advantages of using an AI SCA, built upon historical clinical trial data.
-
AI In Action: Transforming Clinical Trials
1/23/2025
Tala Fakhouri, associate director for data science and ai policy at the FDA, along with industry consultant Elena “Ella” Sinclair of FlexPoint Bio, talk about common applications of AI in clinical development and the new AI-focused regulatory Guidance from the FDA.